Devices › Transcatheter septal occluder
Device brand name · Transcatheter septal occluder
Amplatzer Muscular VSD Occluder: medical device reports filed with FDA
242 reports name it, 2008–2026. Manufacturer given most often on reports: Abbott Medical. Product code MLV.
- 242
- device reports naming the brand
- 0% of all MAUDE reports · about 13 a year
- 44
- reports, 12 months to August 2026
- 26 in the 12 months before
- 24.4%
- classified as malfunction
- 37.8% across the product code
- 9.1%
- classified as death, as reported
- 22 reports · not verified by FDA
242 medical device reports received by FDA name the brand "Amplatzer Muscular VSD Occluder" (transcatheter septal occluder); the manufacturer given most often on reports is Abbott Medical; received from January 2008 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
44 reports arrived in the 12 months to August 2026, up 69% from 26 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (66.1%), malfunction (24.4%) and death (9.1%); across all transcatheter septal occluder reports (product code MLV) death is recorded in 2.8% and malfunction in 37.8%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are migration or expulsion of device (14%), difficult to fold, unfold or collapse (13.2%) and patient device interaction problem (10.3%). The patient problems coded most often are hemolysis, heart block and tricuspid valve insufficiency/ regurgitation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 6,948 reports carrying product code MLV. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Migration or expulsion of device | 34 | 14% | 14.5% |
| Difficult to fold, unfold or collapse | 32 | 13.2% | 26.5% |
| Patient device interaction problem | 25 | 10.3% | 5% |
| Off-label use | 20 | 8.3% | 2.4% |
| Improper or incorrect procedure or method | 3 | 1.2% | 1.4% |
| Insufficient device problem information | 3 | 1.2% | 3.8% |
| Material deformation | 2 | 0.8% | 11.8% |
| Patient-device incompatibilitythe device did not suit the patient | 2 | 0.8% | 2.8% |
| Device damaged by another device | 1 | 0.4% | 0% |
| Difficult to advance | 1 | 0.4% | 0.1% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Hemolysis | 10 | 4.1% |
| Heart block | 8 | 3.3% |
| Tricuspid valve insufficiency/ regurgitation | 8 | 3.3% |
| Arrhythmia | 6 | 2.5% |
| Obstruction/occlusion | 6 | 2.5% |
| Aortic valve insufficiency/ regurgitation | 5 | 2.1% |
| Cardiac tamponade | 5 | 2.1% |
| Perforation | 5 | 2.1% |
| Renal failurekidney failure | 5 | 2.1% |
| Sepsisa severe body-wide response to infection | 5 | 2.1% |
| Anemialow red blood cells | 4 | 1.7% |
| Cardiac arrestthe heart stopped | 4 | 1.7% |
| Heart failure/congestive heart failure | 4 | 1.7% |
| Hemorrhage/blood loss/bleeding | 4 | 1.7% |
| Thrombosis/thrombus | 4 | 1.7% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Amplatzer Muscular VSD Occluder | Product code MLV | All MAUDE reports |
|---|---|---|---|
| Reports | 242 | 6,948 | 26,136,888 |
| Share of that pool | — | 3.5% | 0% |
| Classified as death, per 1,000 reports | 91 | 28 | 9 |
| Classified as injury | 66.1% | 58.1% | 36.2% |
| Classified as malfunction | 24.4% | 37.8% | 62.3% |
| Filed by the manufacturer | 99.2% | 97.4% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code MLV
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Amplatzer Septal Occluder | 3,495 | 406 | 2.4% |
| Amplatzer PFO Occluder | 598 | 42 | 2.8% |
| GORE CARDIOFORM Septal Occluder | 535 | 80 | 1.3% |
| Amplatzer Talisman PFO Occluder | 426 | 125 | 0.9% |
| Gore Helex Septal Occluder | 279 | 0 | 0.4% |
| Amplatzer Cribriform Occluder | 279 | 0 | 0.4% |
| GORE CARDIOFORM ASD Occluder | 274 | 57 | 0.7% |
| Amplatzer Multi-Fenestrated Septal Occluder - Cribriform | 255 | 63 | 0.4% |
| Amplatzer Duct Occluder | 513 | 83 | 2.1% |
| Amplatzer Torqvue Delivery System | 208 | 29 | 7.2% |
| GORE DrySeal Flex Introducer Sheath | 1,177 | 283 | 5.3% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Amplatzer Muscular VSD Occluder reports
How many FDA reports name Amplatzer Muscular VSD Occluder?
242 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 44 in the latest 12 months.
What kinds of events are reported?
injury (66.1%), malfunction (24.4%) and death (9.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
migration or expulsion of device (14%), difficult to fold, unfold or collapse (13.2%), patient device interaction problem (10.3%), off-label use (8.3%) and improper or incorrect procedure or method (1.2%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.2%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Amplatzer Muscular VSD Occluder was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.